Optiscan Imaging Dividends and Buybacks

Dividend criteria checks 0/6

Optiscan Imaging does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-12.5%

Buyback Yield

Total Shareholder Yield	-12.5%
Future Dividend Yield	n/a
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Payout ratio	n/a

Recent dividend and buyback updates

No updates

Recent updates

Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation

Sep 27

Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?

Dec 02

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if OIL's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OIL's dividend payments have been increasing.

Dividend Yield vs Market

Optiscan Imaging Dividend Yield vs Market

How does OIL dividend yield compare to the market?
Segment	Dividend Yield
Company (OIL)	n/a
Market Bottom 25% (AU)	2.6%
Market Top 25% (AU)	6.0%
Industry Average (Medical Equipment)	1.6%
Analyst forecast (OIL) (up to 3 years)	n/a

Notable Dividend: Unable to evaluate OIL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OIL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate OIL's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as OIL has not reported any payouts.

Optiscan Imaging Dividends and Buybacks

Dividend criteria checks 0/6

Key information

Recent dividend and buyback updates

Recent updates

Optiscan Imaging Limited, Annual General Meeting, Nov 21, 2024

Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation

New minor risk - Market cap size

Full year 2024 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2023)

New minor risk - Share price stability

Optiscan Imaging Limited Appoints Brendan Fafiani to the Role of Chief Operating Officer, Effective 6 November 2023

Full year 2023 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2022)

Optiscan Imaging Limited, Annual General Meeting, Nov 23, 2023

New minor risk - Financial data availability

New minor risk - Shareholder dilution

First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.003 loss in 1H 2022)

We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Less than half of directors are independent

We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Full year 2022 earnings released: AU$0.007 loss per share (vs AU$0.004 loss in FY 2021)

Optiscan Imaging Limited, Annual General Meeting, Nov 24, 2022

Optiscan Submits FDA 510(k) Application for InVivage Device

Insider recently bought AU$1.9m worth of stock

Optiscan Imaging Limited Appointment of Sean Gardiner as Non-Executive Director

We're Not Very Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Less than half of directors are independent

Insider recently bought AU$1.2m worth of stock

Insider recently bought AU$1.4m worth of stock

Optiscan Imaging (ASX:OIL) Is In A Strong Position To Grow Its Business

Full year 2021 earnings released: AU$0.004 loss per share (vs AU$0.004 loss in FY 2020)

Non-Executive Director Graeme Mutton has left the company

We're Not Worried About Optiscan Imaging's (ASX:OIL) Cash Burn

Optiscan Imaging Limited Announces Update on seeking United States FDA approval & market entry

How Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?

New 90-day high: AU$0.23

Optiscan Imaging Limited Announces Appointment of Ron Song as New Non-Executive Director

Optiscan Imaging Limited Announces Commencement of Stage Three of its Breast Cancer Study in Melbourne

OptiScan Imaging Limited Receives Orders from Carl Zeiss Meditec AG

Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?

Optiscan Imaging Limited Announces US FDA Regulatory Approval Update

Optiscan Imaging Limited announced that it expects to receive AUD 9.813499 million in funding from Orchid Fund Pte. Limited and other investors

Optiscan Imaging Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.0037 loss per share

Optiscan Image Ltd Ordinary Shares to Be Deleted from Other OTC

Stability and Growth of Payments

Dividend Yield vs Market

Earnings Payout to Shareholders

Cash Payout to Shareholders

Discover strong dividend paying companies